Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 31, 2024

Prognostic and Predictive Value of Immunoscore in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX or CAPOX

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
J. Clin. Oncol 2024 Mar 14;[EPub Ahead of Print], E Domingo, C Kelly, J Hay, O Sansom, N Maka, K Oien, T Iveson, M Saunders, R Kerr, I Tomlinson, J Edwards, A Harkin, M Nowak, V Koelzer, A Easton, I Boukovinas, E Moustou, I Messaritakis, M Chondrozoumaki, M Karagianni, F Pagès, F Arnoux, C Lautard, Y Lovera, I Boquet, A Catteau, J Galon, , I Souglakos, DN Church

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading